| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/04/2011 | US7863301 Increasing glucose-induced insulin secretion from pancreatic beta cells in individuals having hyperglycemia, by administering a pyridine dicarboxylates, inhibitor of prolyl-4-hydroxylase; Type II diabetes |
| 01/04/2011 | US7863265 N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[(2R or S)-2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl-D-lysine, used as anticholesterol agents |
| 01/04/2011 | CA2595782C Process for producing thiazolidinedione compound and production intermediate thereof |
| 01/04/2011 | CA2555331C Therapeutic agents |
| 01/04/2011 | CA2533899C Pyridazine derivatives and their use as therapeutic agents |
| 01/04/2011 | CA2507894C Use of a ppar.alpha. agonist and metformin for decreasing the serum triglycerides |
| 01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 01/04/2011 | CA2463259C Chewable tablet containing lysine |
| 01/04/2011 | CA2455933C Soluble roasted chicory having high inulin content |
| 01/04/2011 | CA2421228C Polyarylcarboxamides useful as lipid lowering agents |
| 01/04/2011 | CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/04/2011 | CA2369694C Agent for improving ketosis |
| 01/04/2011 | CA2365085C Therapeutic agents for diabetes |
| 01/04/2011 | CA2360451C N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance |
| 01/04/2011 | CA2352005C Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use |
| 01/04/2011 | CA2306875C Nutritional supplement for cerebral metabolic insufficiencies |
| 01/04/2011 | CA2304988C Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 01/04/2011 | CA2220091C Nicotinic acid esters and pharmaceutical compositions containing them |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 12/30/2010 | US20100331999 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331420 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331419 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331413 Therapeutic Formulations Based on Asiatic Acid and Selected Salts Thereof |
| 12/30/2010 | US20100331406 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 12/30/2010 | US20100331390 Effects of apolipoprotein b inhibition on gene expression profiles in animals |
| 12/30/2010 | US20100331388 Crystalline Duloxetine Hydrochloride |
| 12/30/2010 | US20100331371 Methyl-benzimidazole derivatives |
| 12/30/2010 | US20100331366 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 12/30/2010 | US20100331360 3-substituted sulfonyl piperidine derivative |
| 12/30/2010 | US20100331350 Inhibitors of bruton's tyrosine kinase |
| 12/30/2010 | US20100331347 (en) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof |
| 12/30/2010 | US20100331346 Beta-amino acid derivatives for treatment of diabetes |
| 12/30/2010 | US20100331344 Modulators of ATP-Binding Cassette Transporters |
| 12/30/2010 | US20100331343 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 12/30/2010 | US20100331342 Immuno Inhibitory Pyrazolone Compounds |
| 12/30/2010 | US20100331339 (1-azinone)-substituted pyridoindoles |
| 12/30/2010 | US20100331338 Glucokinase Activators |
| 12/30/2010 | US20100331333 Imidazo [1,2-B] Pyridazine Compounds |
| 12/30/2010 | US20100331325 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 12/30/2010 | US20100331320 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 12/30/2010 | US20100331312 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 12/30/2010 | US20100331310 Bicycloamine derivatives |
| 12/30/2010 | US20100331298 Carboxamide Compounds and Their Use |
| 12/30/2010 | US20100331297 Modulation of protein trafficking |
| 12/30/2010 | US20100331295 Modulators of lxr |
| 12/30/2010 | US20100331294 4-substituted-2-amino-pyrimidine derivatives |
| 12/30/2010 | US20100331286 Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function |
| 12/30/2010 | US20100331281 Phospholipid compositions and uses thereof |
| 12/30/2010 | US20100331278 Uses of cationic hydroxyethylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders |
| 12/30/2010 | US20100331268 Nitrated Lipids and Methods of Making and Using Thereof |
| 12/30/2010 | US20100331248 Compositions and methods for treating diabetes using lisofylline and islet neogenesis associated peptide |
| 12/30/2010 | US20100331247 Peptide therapy for hyperglycemia |
| 12/30/2010 | US20100331246 Ester-based insulin prodrugs |
| 12/30/2010 | US20100331245 Peptide yy analogs |
| 12/30/2010 | US20100331244 Pharmaceutical composition, food or drink, and methods related thereto |
| 12/30/2010 | US20100331232 Starch-based hydrogel for biomedical applications |
| 12/30/2010 | US20100330673 Methods of making enhanced, autologous fat grafts |
| 12/30/2010 | US20100330177 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 12/30/2010 | US20100330174 Betaine compositions |
| 12/30/2010 | US20100330165 Use of chemotherapeutic agents |
| 12/30/2010 | US20100330157 Biomaterial for the controlled delivery of ingredients |
| 12/30/2010 | US20100330156 Phenazine derivatives and uses thereof |
| 12/30/2010 | US20100330154 amphoteric liposomes comprising neutral lipids |
| 12/30/2010 | US20100330150 Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs |
| 12/30/2010 | US20100330148 Mehods and compositions for inhibiting impdh-1 isoform 1 |
| 12/30/2010 | US20100330117 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c |
| 12/30/2010 | US20100330110 Therapeutic and diagnostic uses of antibody specificity profiles |
| 12/30/2010 | US20100330108 Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| 12/30/2010 | US20100330098 Methods to regulate glucose metabolism |
| 12/30/2010 | US20100330072 Myostatin binding agents |
| 12/30/2010 | US20100330052 Use of Mesenchymal Stem Cells for Treating Genetic Diseases and Disorders |
| 12/30/2010 | US20100330033 Protein-carrier conjugates |
| 12/30/2010 | US20100330021 Substituted (thiazol-2-yl)-amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
| 12/30/2010 | US20100329988 Method for Identifying Within a Mammal a DNA Encoding A Physiologically Active Polypeptide |
| 12/30/2010 | DE10029047B4 Verwendung von Luteolin-7-O-glucuronid als Wirkstoff in einem anticholestatischen Arzneimittel The use of luteolin 7-O-glucuronide as the active ingredient in a pharmaceutical anticholestatischen |
| 12/29/2010 | WO2010151755A2 TREATMENT OF INFLAMMATORY DISEASES USING miR-124 |
| 12/29/2010 | WO2010151611A1 Novel fumarate salts of a histamine h3 receptor antagonist |
| 12/29/2010 | WO2010151565A2 Combination therapies for the treatment of obesity |
| 12/29/2010 | WO2010151503A2 Combination therapies for the treatment of obesity |
| 12/29/2010 | WO2010151426A1 Truncated actriib-fc fusion proteins |
| 12/29/2010 | WO2010151096A1 Therapeutic combinations of nicotinic acid and meldonium |
| 12/29/2010 | WO2010150901A1 Mutant for increasing oleic acid content of soybean oil and fat, and responsible gene therefor |
| 12/29/2010 | WO2010150899A1 Novel thiophene carboxamide derivative and medicinal use of same |
| 12/29/2010 | WO2010150865A1 Crystals |
| 12/29/2010 | WO2010150837A1 Indoline derivative |
| 12/29/2010 | WO2010150650A1 Novel method for maintaining stem cells in an undifferentiated state |
| 12/29/2010 | WO2010150280A1 Disubstituted benzamide derivatives as glucokinase (gk) activators |
| 12/29/2010 | WO2010149815A1 Olive-oil-based functional oils |
| 12/29/2010 | WO2010149778A1 Fish protein hydrolysate for the use thereof in inhibiting weight gain and/or weight loss |
| 12/29/2010 | WO2010149772A1 Preparation comprising insulin, nicotinamide and an amino acid |
| 12/29/2010 | WO2010149685A1 New compounds, pharmaceutical composition and methods relating thereto |
| 12/29/2010 | WO2010149654A1 Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt |
| 12/29/2010 | WO2010149653A1 A pharmaceutical composition comprising meldonium succinate and medical uses thereof |
| 12/29/2010 | WO2010149170A1 Treatment of insulin resistance and obesity by stimulating glp-1 release |
| 12/29/2010 | WO2010148533A1 A pharmaceutical composition with the effect of treating diabetes |
| 12/29/2010 | WO2010129848A3 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides |
| 12/29/2010 | WO2010127246A3 Hnf4 modulators and methods of use |
| 12/29/2010 | WO2010122578A3 Process for preparation of sitagliptin and its intermediates |
| 12/29/2010 | WO2010078324A3 Companion animal compositions including lipoic acid and methods of use thereof |
| 12/29/2010 | WO2010072327A3 Pharmaceutical composition based on peptide from camel milk |